Drugmaker Tranzyme (TZYM) +11.7% premarket on news it will explore a possible sale of the company, less than two years after it went public. Two mid-stage trials of its development drug for stomach paralysis recently were dropped due to lack of efficacy.
joeg1969+ FollowFollowing- Unfollow|Send Message10 Feb 2013
: Definetly !!!!!!!!!!!!Willl see how things play out for a bit before adding .......
joe kelly+ FollowFollowing- Unfollow|Send Message10 Feb 2013
: Bought some last week.
smokeyRose+ FollowFollowing- Unfollow|Send Message15 Nov 2012
Boy am i glad i sold my OCRX yesterday for $4.00 dropped to .99 cents today on Negative news. WOW!!!!
View all 2 replies
Ocean Man+ FollowFollowing- Unfollow|Send Message15 Nov 2012
: You posted 18 Stocktalks yesterday, yet failed to mention that....
smokeyRose+ FollowFollowing- Unfollow|Send Message16 Nov 2012
: Should I have? Had no idea it was going to do that. just lucky I guess
OCRX vs. ETF Alternatives
Ocera Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need.